Home › FDA approves J&J drug for advanced multiple myeloma
 

Keywords :   


FDA approves J&J drug for advanced multiple myeloma

2015-11-16 23:13:12| Biotech - Topix.net

REUTERS: U.S. regulators have approved an experimental treatment from Johnson & Johnson that may offer hope to multiple myeloma patients who have run out of other options against the blood cancer. The U.S. Food and Drug Administration on Monday said it had approved Darzalex for patients who had already undergone at least three prior standard treatments for the cancer, which affects infection-fighting plasma cells that reside in the bone marrow.

Tags: advanced multiple drug fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Henkel Laundry Patent Details Transfer of Encapsulated Fragrance with Dryer Balls
17.05This Week in Waste: Top Stories May 13 May 16, 2024
17.05New Pizza Box Recycling Bins Rolling Out in Central Park, Aiming to Limit Rodent Issues
17.05WM Celebrates Completion of $23 Million in Upgrades at Pittsburgh Facility
17.05Bioenergy Devco's Maryland Bioenergy Center Recycles Food Waste at Full Nameplate Capacity
17.05PNWSCT Coatings Fest 2024 Issues Call for Papers
17.05USDA awards $22.2 million to protect livestock health
17.05USDA awards $22.2 million to protect livestock health
More »